Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.2M Buy
1,838,107
+37,149
+2% +$922K ﹤0.01% 1789
2026
Q2
$49.3M Buy
1,800,958
+1,292,795
+254% +$35.6M 0.01% 1586
2026
Q1
$14.5M Buy
508,163
+485,636
+2,156% +$14.1M ﹤0.01% 2728
2025
Q4
$612K Buy
+22,527
New +$566K ﹤0.01% 8550
2025
Q2
– Sell
-182,405
Closed -$3.83M – 15620
2025
Q1
$3.83M Buy
+182,405
New +$4.12M ﹤0.01% 4329
2024
Q4
– Sell
-525,608
Closed -$9.6M – 15592
2024
Q3
$9.6M Buy
+525,608
New +$9.5M ﹤0.01% 2954

Other funds holding BKV

Ken Griffin's BKV Position: Q3 2026 in Review

Ken Griffin increased its BKV (BKV) stake by 2.1% in Q3 2026, buying an estimated $922K and bringing the position to 1,838,107 shares worth $39.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

Ken Griffin first reported a position in BKV in Q3 2024 and has held it in 6 quarters since. The position peaked at $49.3M in Q2 2026. 170 funds tracked by Wall St. Rank hold BKV as of Q3 2026.

  • Ken Griffin held 1,838,107 shares of BKV worth $39.2M as of Q3 2026.
  • Ken Griffin bought 37,149 BKV shares in Q3 2026, an estimated $922K.
  • BKV made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1789 holding.
  • Ken Griffin first reported a position in BKV in Q3 2024 and has held it in 6 quarters since.
  • Ken Griffin's BKV position peaked at $49.3M in Q2 2026.
  • 170 funds tracked by Wall St. Rank held BKV as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.